Close Menu

Phenomenex

In Life Sciences, CEO Thomas Joyce noted a strong performance by Beckman Coulter, while in Diagnostics, he said Cepheid grew 25 percent year over year. 

The company has shut down the Veris molecular diagnostics product line, which Beckman Coulter spent years developing, as a result of its acquisition of Cepheid.

Phenomenex, a privately held manufacturer of consumables for the separation sciences, will operate as a standalone business and will retain its brand. 

The partners will co-market the Phenomenex Strata and Strata-X SPE sorbents adapted to Tecan's Freedom EVO series of robotic workstations.

MyCartis this week launched its Evaluation multiplex biomarker analysis system.
The system is intended for simultaneous analysis of multiple protein and nucleic acid markers and features an integrated reaction and detection environment, the company said.

Phenomenex this week released its Kinetex EVO C18 UPLC column. According to the company the column incorporates a patented organo-silica grafting process that utilizes uniform stabilizing ethane cross-linking" and offers high selectivity and pH stability from one to 12.

New Products: Phenomenex Aeris

Premium

Phenomenex has added 5 µm particle size to its family of Aeris PEPTIDE core-shell columns. The new column enables higher efficiencies and higher loading capability for small-scale peptide purification, the company said.

Phenomenex said that its spin-off firm, Neoteryx, has released its Mitra Microsampling Device.

NEW YORK (GenomeWeb) – Phenomenex said this week that it is spinning off a new biological samples company, Neoteryx, focused on providing microsampling products that enable simpler, less invasive, and cost-effective methods of collecting and testing biological samples.

Protein Metrics has launched top-down proteomic analysis as part of the 2.0 release of its Byonic proteomics search engine.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.